Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet Uveitis

  • Ilknur Tugal-Tutkun
  • Kürsat Cingü
  • Nur Kir
  • Baris Yeniad
  • Meri Urgancioglu
  • Ahmet Gül
Inflammatory Disorders



To assess the usefulness of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet disease.


The study comprised 47 healthy individuals, 78 Behçet patients without ocular involvement, 54 Behçet patients with a uveitis attack and 53 Behçet patients with uveitis in clinical remission. A single observer assigned clinical scores to anterior chamber cells, vitreous haze, and fundus lesions in the attack group. Laser flare-cell photometry measurements were performed by another observer who was masked to the clinical findings. Fundus fluorescein angiography was performed only in the remission group, and fluorescein leakage was scored by a masked retina specialist. The risk of recurrent uveitis attack was analyzed in eyes with high versus low flare values in the remission group. Main outcome measures were anterior chamber flare in Behçet patients compared to the control group, and correlations of flare with clinical scores of intraocular inflammation and with fluorescein leakage. Mann-Whitney U-test, Spearman’s bivariate correlation test, linear regression method, and Kaplan-Meier method were used for statistical analyses.


Mean flare was not increased in Behçet patients without ocular involvement. It was significantly higher in patients with Behçet uveitis both during attacks and in remission (P < 0.001 for each). A significant correlation was found between anterior chamber flare and anterior chamber cell score (rho = 0.705), vitreous haze score (rho = 0.588), and fundus score (rho = 0.464) in the attack group. In the remission group, there was a significant correlation between flare and fluorescein angiography leakage score, and the risk of recurrent uveitis attack was significantly higher in eyes with flare values >6 photons/msec than in eyes with flare values ≤6 photons/msec (right eyes, P < 0.001; left eyes, P = 0.0184).


Laser flare-cell photometry is a useful objective method in the quantitative assessment of intraocular inflammation in patients with Behçet uveitis. The use of this quantitative technique in clinical trials of Behçet uveitis may provide comparable data, as it gives an objective measure of intraocular inflammation. In clinical practice, it may reduce the need for fluorescein angiography because it seems to be especially useful in monitoring persistent retinal vascular leakage in patients who are clinically in remission.


Behçet disease Uveitis Laser flare-cell photometry 



This study was supported by the Research Fund of Istanbul University (Project number 53/03062005)

We thank Professor Rian Disci for statistical assistance.


  1. 1.
    Yazici H, Yurdakul S, Hamuryudan V (1999) Behçet’s syndrome. Curr Opin Rheumatol 11:53–57PubMedCrossRefGoogle Scholar
  2. 2.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M (2004) Uveitis in Behçet disease: An analysis of 880 patients. Am J Ophthalmol 138:373–380PubMedCrossRefGoogle Scholar
  3. 3.
    Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H Verhoeff lecture. presented by Saiichi Mishima, MD Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225–279PubMedGoogle Scholar
  4. 4.
    Takeuchi M, Hokama H, Tsukahara R et al (2005) Risk and prognostic factors of poor visual outcome in Behçet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243:1147–1152PubMedCrossRefGoogle Scholar
  5. 5.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Kir N, Urgancioglu M (2006) Neovascularization of the optic disc in Behçet’s disease. Jpn J Ophthalmol 50:256–265PubMedCrossRefGoogle Scholar
  6. 6.
    Mochizuki M, Akduman L, Nussenblatt RB (1996) Behçet disease. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection & immunity. Mosby, St Louis, pp 663–675Google Scholar
  7. 7.
    Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN (2005) Laser flare-cell photometry: Methodology and clinical applications. Surv Ophthalmol 50:27–47PubMedCrossRefGoogle Scholar
  8. 8.
    Guex-Crosier Y, Pittet N, Herbort CP (1994) Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology 101:728–735PubMedGoogle Scholar
  9. 9.
    Guex-Crosier Y, Pittet N, Herbort CP (1995) Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment. Ophthalmology 102:613–621PubMedGoogle Scholar
  10. 10.
    Herbort CP, Guex-Crosier Y, de Ancos E, Pittet N (1997) Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 104:64–72PubMedGoogle Scholar
  11. 11.
    Magone MT, Nussenblatt RB, Whitcup SM (1997) Elevation of laser flare photometry in patients with cytomegalovirus retinitis and AIDS. Am J Ophthalmol 124:190–198PubMedGoogle Scholar
  12. 12.
    Gonzales CA, Ladas JG, Davis JL, Feuer WJ, Holland GN (2001) Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol 119:1763–1769PubMedGoogle Scholar
  13. 13.
    Davis JL, Dacanay LM, Holland GN, Berrocal AM, Giese MS, Feuer WJ (2003) Laser flare photometry and complications of uveitis in children. Am J Ophthalmol 135:763–771PubMedCrossRefGoogle Scholar
  14. 14.
    Nguyen NX, Schonherr U, Kuchle M (1995) Aqueous flare and retinal capillary changes in eyes with diabetic retinopathy. Ophthalmologica 209:145–148PubMedCrossRefGoogle Scholar
  15. 15.
    Nguyen NX, Kuchle M (1993) Aqueous flare and cells in eyes with retinal vein occlusion–correlation with retinal fluorescein angiographic findings. Br J Ophthalmol 77:280–283PubMedCrossRefGoogle Scholar
  16. 16.
    Kuchle M, Nguyen NX, Martus P, Freissler K, Schalnus R (1998) Aqueous flare in retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 236:426–433PubMedCrossRefGoogle Scholar
  17. 17.
    International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080Google Scholar
  18. 18.
    Shah SM, Spalton DJ, Smith SE (1991) Measurement of aqueous cells and flare in normal eyes. Br J Ophthalmol 75:348–352PubMedCrossRefGoogle Scholar
  19. 19.
    Guillen-Monterrubio OM, Hartikainen J, Taskinen K, Saari KM (1997) Quantitative determination of aqueous flare and cells in healthy eyes. Acta Ophthalmol Scand 75:58–62PubMedCrossRefGoogle Scholar
  20. 20.
    Onodera T, Gimbel HV, DeBroff BM (1993) Aqueous flare and cell number in healthy eyes of Caucasians. Jpn J Ophthalmol 37:445–451PubMedGoogle Scholar
  21. 21.
    Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516PubMedCrossRefGoogle Scholar
  22. 22.
    BenEzra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P (1991) Uveitis scoring system. Springer Verlag, BerlinGoogle Scholar
  23. 23.
    El-Maghraby A, Marzouki A, Matheen TM, Souchek J, Van der Karr M (1992) Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation. Arch Ophthalmol 110:960–962PubMedGoogle Scholar
  24. 24.
    Okamoto F, Umebayasi Y, Ohtsuka F, Hommura S (2001) Factors associated with increased aqueous flare in psoriasis. Jpn J Ophthalmol 45:172–176PubMedCrossRefGoogle Scholar
  25. 25.
    Sfikakis PP, Kaklamanis PH, Elezoglou A et al (2004) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diease. Ann Intern Med 140:404–406PubMedGoogle Scholar
  26. 26.
    Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease. Arthritis Rheum 52:2478–2484PubMedCrossRefGoogle Scholar
  27. 27.
    Kötter I, Zierhut M, Eckstein AK et al (2003) Human recombinant interferon alfa-2a for the treatment of Bençet’s disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423–431PubMedCrossRefGoogle Scholar
  28. 28.
    Schalnus RW, Ohrloff C (1998) Vergleichende Lasertyndallometrie und Fluorophotometrie bei anteriorer und posteriorer Uveitis. Ophthalmologe 95:3–7PubMedCrossRefGoogle Scholar
  29. 29.
    Takeuchi M, Hokama H, Tsukahara R et al (2005) Risk and prognostic factors of poor visual outcome in Behcet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243:1147–1152PubMedCrossRefGoogle Scholar
  30. 30.
    Atmaca LS (1989) Fundus changes associated with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol 227:340–344PubMedCrossRefGoogle Scholar
  31. 31.
    Klaeger A, Tran AT, Hiroz CA, Morisod L, Herbort CP (2000) Indocyanine green angiography in Behçet’s uveitis. Retina 20:309–314PubMedGoogle Scholar
  32. 32.
    Gedik S, Akova YA, Yilmaz G, Bozbeyoglu S (2005) Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behçet’s disease. Ocul Immunol Inflamm 13:51–58PubMedCrossRefGoogle Scholar
  33. 33.
    Atmaca LS, Sonmez PA (2003) Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol 87:1466–1468PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Ilknur Tugal-Tutkun
    • 1
    • 3
  • Kürsat Cingü
    • 1
  • Nur Kir
    • 1
  • Baris Yeniad
    • 1
  • Meri Urgancioglu
    • 1
  • Ahmet Gül
    • 2
  1. 1.Department of Ophthalmology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey
  2. 2.Department of Internal Medicine, Division of Rheumatology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey
  3. 3.Istanbul Tip Fakultesi, Göz Hastaliklari A.D.IstanbulTurkey

Personalised recommendations